<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
h1
{mso-style-priority:1;
mso-style-link:"Heading 1 Char";
margin-top:4.95pt;
margin-right:0in;
margin-bottom:0in;
margin-left:0in;
margin-bottom:.0001pt;
text-align:center;
font-size:24.0pt;
font-family:"Calibri","sans-serif";
color:#1F497D;
letter-spacing:-.55pt;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin:0in;
margin-bottom:.0001pt;
text-align:center;
text-autospace:none;
font-size:14.0pt;
font-family:"Calibri","sans-serif";
font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-priority:1;
mso-style-link:"Body Text Char";
margin:0in;
margin-bottom:.0001pt;
text-autospace:none;
font-size:12.0pt;
font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:1;
mso-style-link:"Heading 1";
font-family:"Times New Roman","serif";
color:#1F497D;
letter-spacing:-.55pt;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Arial","sans-serif";
font-weight:bold;
font-style:italic;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-priority:1;
mso-style-link:"Body Text";
font-family:"Arial","sans-serif";}
span.EmailStyle21
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle23
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hello everyone,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>I learned that, for some, this previously sent email never made it out of my computer. I think I have corrected the outbox issues and am going to try and send this info to you again.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Also with all the resending that I am doing tonight, the email with the Fact Sheet 3 of 4 might have had a subject line that did not match the attachment or the body. Just focus on the attachment and the body of the emails and don’t get too hung up on the subject line, (it may confuse just a bit…sorry about that).<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Please forgive any duplicate emails with this subject and attachment.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Sincerely,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Russ<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Russell Davis [mailto:russell@radiorusty.com] <br><b>Sent:</b> Monday, January 10, 2022 2:35 PM<br><b>To:</b> nfbf-l@nfbnet.org; nfbf-leaders@nfbnet.org<br><b>Subject:</b> Fact Sheets for 2022 NFB Washington Seminar - 2 of 4 - Medical Device Non-Visual Access<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Hello <span style='color:#1F497D'>again </span>everyone,<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Please see attached the <span style='color:#1F497D'>Medical Device Non Visual Accessibility </span>Act fact sheet in Microsoft Word format.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>For your convenience, I’ve also pasted the text of the fact sheet to the bottom of this email.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Please take the time to review the fact sheet as it will provide you with valuable information about this bill.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Thanks so much for all you are doing to help move forward our mission and our legislative efforts.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Respectfully,<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal>Russ Davis,<o:p></o:p></p><p class=MsoNormal>Legislative Director, National Federaton of the Blind of Florida<o:p></o:p></p><p class=MsoNormal>Ph. 904-993-8433<o:p></o:p></p><p class=MsoNormal>Email: <a href="mailto:Russell@radiorusty.com">Russell@radiorusty.com</a><o:p></o:p></p><p class=MsoBodyText><span style='font-size:10.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><h1>MEDICAL DEVICE NONVISUAL ACCESSIBILITY ACT (H.R. 4853)<span style='font-size:26.0pt'><o:p></o:p></span></h1><h2>Issue—Inaccessible digital interfaces prevent blind individuals from independently and safely operating medical devices that are essential to their daily healthcare needs. <o:p></o:p></h2><p class=MsoNormalCxSpFirst style='margin-right:23.4pt;mso-add-space:auto'><b><span style='font-size:11.5pt;color:#ED1C24'><o:p> </o:p></span></b></p><p class=MsoNormalCxSpMiddle style='margin-right:23.4pt;mso-add-space:auto'><b><span style='font-size:11.5pt;color:#ED1C24'>Medical devices with a digital interface are becoming more prevalent and less accessible for blind Americans. </span></b><span style='font-size:11.5pt'>The rapid proliferation of advanced technology is undeniable. Most new models of medical devices, such as glucose and blood pressure monitors, along with the emergence of in-home devices that offer medical care options, such as chemotherapy treatments and dialysis, require consumers to interact with a digital display or other interfaces. This new technology has been <a name="_Hlk61018618">and continues to be </a>developed and deployed without nonvisual accessibility as an integral part of the design phase, which creates a modern-day barrier. The inaccessibility of these medical devices is not a mere inconvenience; if accessibility for blind consumers is omitted from the medical technology landscape, the health, safety, and independence of blind Americans will be in imminent danger.<o:p></o:p></span></p><p class=MsoNormalCxSpLast style='margin-right:23.4pt;mso-add-space:auto'><span style='font-size:11.5pt'><o:p> </o:p></span></p><p class=MsoBodyTextCxSpFirst style='mso-margin-top-alt:.1pt;margin-right:16.0pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto'><a name="_Hlk61018851"><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif";color:#ED1C24'>Telehealth currently makes up 20 percent of all medical visits, and more healthcare providers are looking to expand telemedicine services.</span></b></a><a href="#_bookmark0"><span style='font-size:8.0pt;font-family:"Calibri","sans-serif";color:windowtext;position:relative;top:-4.0pt;mso-text-raise:4.0pt;text-decoration:none'>1 </span></a><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'>Unfortunately, these visits assume that a person has easy access to accessible medical devices in order to take their own vitals. As a result of inaccessibility, blind and low-vision Americans are at a distinct disadvantage when it comes to receiving the same virtual healthcare as their sighted counterparts. </span><span style='font-size:8.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoBodyTextCxSpMiddle style='margin-top:.55pt;mso-add-space:auto'><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoBodyTextCxSpMiddle style='margin-right:8.05pt;mso-add-space:auto'><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif";color:#ED1C24'>Nonvisual access is achievable, as demonstrated by a number of mainstream products. </span></b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'>Apple has incorporated VoiceOver (a text-to-speech function) into all of their products, making iPhones, Macbooks and Mac desktops, and iPads fully accessible to blind people right out of the box. Virtually all ATMs manufactured in the United States are accessible, and every polling place is required to have a nonvisually accessible voting machine. Frequently, a simple audio output or vibrotactile feature can make a product accessible at little to no additional cost for manufacturers.<o:p></o:p></span></p><p class=MsoBodyTextCxSpMiddle style='margin-right:8.05pt;mso-add-space:auto'><b><span style='font-family:"Calibri","sans-serif";color:#ED1C24'><o:p> </o:p></span></b></p><p class=MsoBodyTextCxSpLast style='margin-right:8.05pt;mso-add-space:auto'><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif";color:#ED1C24'>Current disability laws are not able to keep up with advancements due to the expeditious evolution of medical technology and its incorporation into medical devices. </span></b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'>Although the Americans with Disabilities Act and other laws require physical accessibility for people with disabilities (e.g., wheelchair ramps, Braille in public buildings), no laws protect the blind consumer’s right to access medical devices. The National Council on Disability concluded that accessibility standards lag behind the rapid pace of technology, which can interfere with technology access.</span><a href="#_bookmark2"><span style='font-size:8.0pt;font-family:"Calibri","sans-serif";color:windowtext;position:relative;top:-4.0pt;mso-text-raise:4.0pt;text-decoration:none'>2 </span></a><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'>This trend of inaccessibility will continue if accessibility solutions are ignored. Only a fraction of medical device manufacturers has incorporated nonvisual access standards into their product design, while others continue to resist these solutions.<o:p></o:p></span></p><b><i><span style='font-size:14.0pt;font-family:"Calibri","sans-serif";mso-fareast-language:EN-US'><br clear=all style='page-break-before:always'></span></i></b><h2>Solution—Medical Device Nonvisual Accessibility Act (H.R. 4853):<o:p></o:p></h2><p class=MsoBodyTextCxSpFirst style='margin-top:.5pt;mso-add-space:auto'><b><i><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></i></b></p><p class=MsoBodyTextCxSpMiddle style='mso-margin-top-alt:0in;margin-right:5.5pt;margin-bottom:0in;margin-left:6.0pt;margin-bottom:.0001pt;mso-add-space:auto'><b><span style='font-family:"Calibri","sans-serif";color:#005F95'>Calls on the Food and Drug Administration (FDA) to promulgate nonvisual accessibility standards for Class II and Class III medical devices. </span></b><a name="_Hlk61019190"><span style='font-family:"Calibri","sans-serif"'>The FDA will consult with stakeholders with disabilities and manufacturers and issue a notice of proposed rulemaking no later than twelve months after the date of enactment of the act. </span></a><span style='font-family:"Calibri","sans-serif"'>No later than 24 months after the date of enactment of the act, the FDA will publish the final rule including the nonvisual accessibility standards.<o:p></o:p></span></p><p class=MsoBodyTextCxSpMiddle style='mso-margin-top-alt:0in;margin-right:5.5pt;margin-bottom:0in;margin-left:6.0pt;margin-bottom:.0001pt;mso-add-space:auto'><span style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoBodyTextCxSpMiddle style='mso-margin-top-alt:0in;margin-right:5.5pt;margin-bottom:0in;margin-left:6.0pt;margin-bottom:.0001pt;mso-add-space:auto'><b><span style='font-family:"Calibri","sans-serif";color:#005F95'>Requires manufacturers of Class II and Class III medical devices to make their products nonvisually accessible.</span></b><span style='font-family:"Calibri","sans-serif"'> Manufacturers will have twelve months following the publication of the final rule to ensure that all of the Class II and Class III medical devices they produce are nonvisually accessible. <o:p></o:p></span></p><p class=MsoBodyText><span style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormalCxSpFirst style='mso-margin-top-alt:0in;margin-right:6.8pt;margin-bottom:0in;margin-left:5.95pt;margin-bottom:.0001pt;mso-add-space:auto'><b><span style='font-size:12.0pt;color:#005F95'>Authorizes the FDA to enforce the nonvisual access standards for Class II and Class III medical devices.</span></b><span style='font-size:12.0pt'> Any manufactured device found to be out of compliance, whether by a public complaint to the FDA or by an independent FDA investigation, will be considered an adulterated product under the Federal Food, Drug, and Cosmetic Act.<o:p></o:p></span></p><p class=MsoNormalCxSpMiddle style='mso-margin-top-alt:0in;margin-right:6.8pt;margin-bottom:0in;margin-left:5.95pt;margin-bottom:.0001pt;mso-add-space:auto'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpLast style='mso-margin-top-alt:0in;margin-right:6.8pt;margin-bottom:0in;margin-left:5.95pt;margin-bottom:.0001pt;mso-add-space:auto'><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoBodyText align=center style='text-align:center'><b><span style='font-size:17.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>GOAL—END UNEQUAL ACCESS TO MEDICAL DEVICES FOR BLIND AMERICANS.<o:p></o:p></span></b></p><p class=MsoBodyText><o:p> </o:p></p><h2>Cosponsor the Medical Device Nonvisual Accessibility Act (H.R. 4853)<o:p></o:p></h2><p class=MsoBodyText style='margin-top:.5pt;mso-add-space:auto'><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:12.0pt'>To cosponsor H.R. 4853 contact:<o:p></o:p></span></b></p><p class=MsoBodyText align=center style='text-align:center'><span style='font-family:"Calibri","sans-serif"'>Gidget Benitez, Health Policy Counsel, Rep. Jan Schakowsky (D-IL-09)<br>Phone: 202-225-2111, Email: </span><a href="mailto:gidget.benitez@mail.house.gov"><span style='font-family:"Calibri","sans-serif"'>gidget.benitez@mail.house.gov</span></a><span style='font-family:"Calibri","sans-serif"'> </span><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></b></p><p class=MsoBodyTextCxSpLast style='margin-top:.5pt;mso-add-space:auto'><b><span style='font-size:11.5pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></b></p><p class=MsoNormal align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.5pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><b><span style='font-size:12.0pt'>For more information, contact:<o:p></o:p></span></b></p><p class=MsoBodyText align=center style='mso-margin-top-alt:0in;margin-right:28.0pt;margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><span style='font-family:"Calibri","sans-serif"'>Jesa Medders, National Federation of the Blind<br>Phone: 410-659-9314, extension 2207, Email: </span><a href="mailto:jmedders@nfb.org"><span style='font-family:"Calibri","sans-serif"'>jmedders@nfb.org</span></a><u><span style='font-family:"Calibri","sans-serif";color:blue'><br></span></u><a href="http://www.nfb.org/"><span style='font-family:"Calibri","sans-serif"'>www.nfb.org</span></a><span style='font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormalCxSpFirst align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><span style='font-size:12.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:0in;margin-right:6.5pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><!--[if gte vml 1]><o:wrapblock><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Straight_x0020_Connector_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" style='position:absolute;left:0;text-align:left;margin-left:45pt;margin-top:19.25pt;width:144.75pt;height:.75pt;z-index:-251658752;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:page;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;mso-height-relative:page'>
<v:imagedata src="cid:image001.png@01D8062F.4D9FD6A0" o:title="" />
<o:lock v:ext="edit" aspectratio="f" />
<w:wrap type="topAndBottom" anchorx="page"/>
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'><table cellpadding=0 cellspacing=0 align=left><tr><td width=60 height=0></td></tr><tr><td></td><td><img width=193 height=1 src="cid:image001.png@01D8062F.4D9FD6A0" v:shapes="Straight_x0020_Connector_x0020_2"></td></tr></table></span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br style='mso-ignore:vglayout' clear=ALL><i><span style='font-size:14.5pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></i></p><p class=MsoNormalCxSpMiddle style='mso-margin-top-alt:4.15pt;margin-right:26.15pt;margin-bottom:0in;margin-left:5.95pt;margin-bottom:.0001pt;mso-add-space:auto'><a name="_bookmark0"></a><span style='font-size:6.0pt;position:relative;top:-3.0pt;mso-text-raise:3.0pt'><o:p> </o:p></span></p><p class=MsoNormalCxSpMiddle style='mso-margin-top-alt:4.15pt;margin-right:26.15pt;margin-bottom:12.0pt;margin-left:5.95pt;mso-add-space:auto'><span style='font-size:6.0pt;position:relative;top:-3.0pt;mso-text-raise:3.0pt'>1</span><i><span style='font-size:9.0pt'> See </span></i><span style='font-size:9.0pt'>Center for Connected Medicine<i>, Telehealth utilization settles in at 20% or less of medical appointments</i>, available at<i> </i></span><a href="https://connectedmed.com/resources/post-pandemic-telehealth-utilization-settles-in-at-20-or-less-of-medical-appointments/"><span style='font-size:9.0pt'>https://connectedmed.com/resources/post-pandemic-telehealth-utilization-settles-in-at-20-or-less-of-medical-appointments/</span></a><span style='font-size:9.0pt'> </span><span style='font-size:6.0pt;position:relative;top:-3.0pt;mso-text-raise:3.0pt'><br>2</span><i><span style='font-size:9.0pt'>See </span></i><span style='font-size:9.0pt'>N</span><span style='font-size:7.0pt'>ATIONAL </span><span style='font-size:9.0pt'>C</span><span style='font-size:7.0pt'>OUNCIL ON </span><span style='font-size:9.0pt'>D</span><span style='font-size:7.0pt'>ISABILITIES</span><span style='font-size:9.0pt'>, <i>National Disability Policy Progress Report: Technology that enables access to the full opportunities of citizenship under the Constitution is a right </i>at 19 (October 7, 2016), <i>available at </i></span><a href="https://ncd.gov/progressreport/2016/progress-report-october-2016"><span style='font-size:9.0pt'>https://ncd.gov/progressreport/2016/progress-report-october-2016</span></a><a name="_bookmark1"></a><span style='font-size:10.0pt'><o:p></o:p></span></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:4.7pt;margin-right:6.1pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><b><span style='font-size:9.5pt;color:#5398D2'><o:p> </o:p></span></b></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:4.7pt;margin-right:6.1pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><b><span style='font-size:9.5pt;color:#5398D2'><o:p> </o:p></span></b></p><p class=MsoNormalCxSpMiddle align=center style='mso-margin-top-alt:4.7pt;margin-right:6.1pt;margin-bottom:0in;margin-left:8.6pt;margin-bottom:.0001pt;mso-add-space:auto;text-align:center'><b><span style='font-size:9.5pt;color:#5398D2'><o:p> </o:p></span></b></p><p class=MsoNormalCxSpMiddle style='mso-margin-top-alt:4.7pt;margin-right:6.1pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto'><b><span style='font-size:9.5pt'><o:p> </o:p></span></b></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p></div></body></html>